Skip to content
Clinical Trials – home
GermanyBack to Germany

Clinical trials in Ludwigshafen Am Rhein – page 7

99 clinical trials in Ludwigshafen Am Rhein, Germany. Every trial is listed in the EU Clinical Trials Register and updated daily.

GermanyOur site in GermanyKlinischeStudien.de(opens in a new tab)
Ludwigshafen Am Rhein at a glance
99
clinical trials
  • Paediatric trials0
  • Research sites0
Type of trial
Recruitment status
Quick filters

99 trials in Ludwigshafen Am Rhein

Open in trial search
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Ivosidenib
  • Sponsor:Medizinische Hochschule Hannover

Colitis ulcerative

Not recruiting
Registered drug
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Metronidazole
  • Sponsor:Friedrich-Schiller-Universitaet Jena
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Glofitamab
  • Sponsor:Frankfurter Institut Fuer Klinische Krebsforschung IKF GmbH
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Enasidenib Mesilate
  • Sponsor:Hemato-Oncologie voor Volwassenen Nederland (Hovon) Stichting
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Carboplatin
  • Sponsor:GWT-Tud GmbH
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Dapagliflozin
  • Sponsor:Eli Lilly & Co.
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Cytarabine
  • Sponsor:Universitaetsklinikum Ulm AöR
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Aflibercept
  • Sponsor:AbbVie Deutschland GmbH & Co. KG

Cardiac failure

Not recruiting
Registered drug
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Azilsartan Medoxomil
  • Sponsor:Novartis Pharma AG
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Allogeneic Skin-Derived Abcb5-Positive Dermal Mesenchymal Stromal Cells
  • Sponsor:Rheacell GmbH & Co. KG
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Ociperlimab
  • Sponsor:Beigene Ltd.
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Cyclophosphamide
  • Sponsor:AbbVie Deutschland GmbH & Co. KG

Other cities in Germany

The busiest research cities in the country

All 515 cities in Germany

Clinical research in Ludwigshafen Am Rhein

What the registry says about research in the country

01 Ophthalmology Research

Groundbreaking trials focusing on age-related macular degeneration and retinal conditions, including studies of innovative treatments for geographic atrophy and wet AMD. Research encompasses new drug delivery systems and therapeutic approaches for retinal vein occlusion.

  • Macular Degeneration Therapies
  • Retinal Vascular Disorders
  • Vision Preservation Treatments
02 Gastroenterology Studies

Multiple investigations into inflammatory bowel diseases, with particular focus on Crohn's Disease and ulcerative colitis. Studies evaluate novel therapeutic combinations and long-term treatment efficacy.

  • Crohn's Disease Management
  • Ulcerative Colitis Treatments
  • Innovative Drug Therapies
03 Oncology & Hematology

Advanced research in blood cancers and solid tumors, including studies on multiple myeloma, acute myeloid leukemia, and non-small cell lung cancer. Trials explore innovative combination therapies and maintenance treatments.

  • Blood Cancer Therapies
  • Lymphoma Treatments
  • Targeted Cancer Therapies
04 Cardiovascular Medicine

Critical studies addressing acute myocardial infarction and related conditions. Research focuses on emergency interventions and preventive treatments for patients at risk of recurrent heart attacks.

  • Heart Attack Prevention
  • Emergency Cardiac Care
  • Innovative Cardiac Therapies
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.